P-174 - RANDOMIZED OPEN-LABEL STUDY TO ASSESS RELATIVE BIOAVAILABILITY OF DIFFERENT ORAL FORMULATIONS, THE EFFECT OF FOOD ON ABSORPTION AND ABSOLUTE BIOAVAILABILITY OF AZD9833 (CAMIZESTRANT) IN POST-MENOPAUSAL HEALTHY FEMALE VOLUNTEERS.
A. Sykes1, H. Engman2, N. Taylor3, T. Brier1, R. Maudsley1, B. Kirova1, A. Mathewson1, R. Bragg1, M. Gränfors2, T. Klinowska1, Y. Li4, S. Menakuru5, C. Roe5, J. McDermott5, J. Lindemann1; 1AstraZeneca, Cambridge, United Kingdom, 2AstraZeneca, Mölndal, Sweden, 3AstraZeneca, Macclesfield, United Kingdom, 4AstraZeneca, Boston, MA, USA, 5Quotient Sciences, Nottingham, United Kingdom.